AZELASTINE FLUTICASO Spirig HC 0.14/0.05mg 120 dos

7680689800011 CH-68980 R01AD58 12.02.2.

Active substances:

Reimbursement limitations:

ZAVESCA

Pour le traitement des patients adultes atteints d'une maladie de Gaucher de type 1 dans …

AZELASTINE FLUTICASO Spirig HC 0.14/0.05mg 120 dos
AZELASTINE FLUTICASO Spirig HC 0.14/0.05mg 120 dos
AZELASTINE FLUTICASO Spirig HC 0.14/0.05mg 120 dos
1 / 3
google

Details

Product number
6898001
CPT
-
Packaging group
25
Unit
ml
Composition
azelastini hydrochloridum 0.137 mg, fluticasoni propionas 0.05 mg, glycerolum, cellulosum microcristallinum et carmellosum natricum, dinatrii edetas, polysorbatum 80, benzalkonii chloridum 0.014 mg, alcohol phenylethylicus, aqua purificata, ad suspensionem pro dosi, doses pro vase 120.

Articles (1)

Azelastin Fluticason Spirig HC Nasenspray, Suspension
suspension
25
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
23/04/2026
Patient information leaflet
Français
23/04/2026
Patient information leaflet
Italien
23/04/2026
Professional SmPC
Allemand
23/04/2026
Professional SmPC
Français
23/04/2026
Professional SmPC
Italien
23/04/2026

Detailed composition

Substance Quantity Type Category
azelastini hydrochloridum
0.137 MG Substance Wirkstoff (Principe actif)
fluticasoni propionas
0.05 MG Substance Wirkstoff (Principe actif)
glycerolum
- Substance HNIDK
cellulosum microcristallinum et carmellosum natricum
- Substance HNIDK
dinatrii edetas
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
benzalkonii chloridum
0.014 MG Substance HBESI
alcohol phenylethylicus
- Substance Konservierungsstoff (Conservateur)
aqua purificata
- Substance HNIDK

Reimbursement information

Public price
CHF 29.60
Specialties list
Yes
Generic
Yes
SL addition date: 01/03/2024

Authorization holder

Spirig HealthCare AG

4622 Egerkingen

Authorization information

Swissmedic authorization number
68980
Drug name
Azelastin Fluticason Spirig HC Nasenspray, Suspension
Galenic form
NASSS
ATC Code
R01AD58
Authorization status
Z
Dispensation category
B
First authorization
18/12/2023
Authorization expiration date
17/12/2028
IT number
12.02.2.
Domain
Human medicine
Field of application
Saisonaler und perennialer allergischer Schnupfen

Packaging details

Description (FR)
AZELASTINE FLUTICASO Spirig HC 0.14/0.05mg 120 dos
Description (DE)
AZELASTIN FLUTICASON Spirig HC 0.14/0.05mg 120 Dos
Market launch
18/12/2023
Narcotic (BTM)
No

Original drug

Dymista Nasenspray, Suspension
CHF 31.80
View original
Buy us a coffee Explore the data